Increased oxidative stress in obesity: Implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer

Obesity Research and Clinical Practice

Volumn 7, Issue 5, 2013, Pages

  Matsuda, Morihiro ^a   Shimomura, Iichiro ^b  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Metabolic syndrome; Obesity; Oxidative stress

Indexed keywords

ADIPOCYTOKINE; ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIOXIDANT; APOLIPOPROTEIN B; CATALASE; CYTOKINE; FATTY ACID; GLITAZONE DERIVATIVE; GLUCOSE; GLUTATHIONE PEROXIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SOMATOMEDIN C; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN;

ABDOMINAL OBESITY; ADIPOSE TISSUE; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CALORIC RESTRICTION; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIETARY INTAKE; DYSLIPIDEMIA; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIFESTYLE MODIFICATION; LIPID STORAGE; METABOLIC SYNDROME X; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OVERNUTRITION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

MUS;

ADIPOSE TISSUE; ANIMALS; ATHEROSCLEROSIS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; HUMANS; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NEOPLASMS; OBESITY; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84884597384     PISSN: 1871403X     EISSN: 18780318     Source Type: Journal    
DOI: 10.1016/j.orcp.2013.05.004     Document Type: Review

References (117)

1. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 15 1998 539 553
2. Y. Matsuzawa, T. Funahashi, and T. Nakamura Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances Ann N Y Acad Sci 892 1999 146 154
3. Y. Matsuzawa, T. Nakamura, I. Shimomura, and K. Kotani Visceral fat accumulation and cardiovascular disease Obes Res 3 Suppl. 5 1995 645S 647S
4. A. Hiuge-Shimizu, K. Kishida, T. Funahashi, Y. Ishizaka, R. Oka, and M. Okada Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study) Ann Med 44 2012 82 92
5. K. Kishida, T. Funahashi, and I. Shimomura Clinical importance of assessment of type 2 diabetes mellitus with visceral obesity. A Japanese perspective Curr Diabetes Rev 8 2012 84 91
6. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 1993 87 91
7. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. Obesity is associated with macrophage accumulation in adipose tissue J Clin Invest 112 2003 1796 1808
8. H. Xu, G.T. Barnes, Q. Yang, G. Tan, D. Yang, and C.J. Chou Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J Clin Invest 112 2003 1821 1830
9. H. Sies Oxidative stress: oxidants and antioxidants Exp Physiol 82 1997 291 295
10. S. Furukawa, T. Fujita, M. Shimabukuro, M. Iwaki, Y. Yamada, and Y. Nakajima Increased oxidative stress in obesity and its impact on metabolic syndrome J Clin Invest 114 2004 1752 1761
11. N. Houstis, E.D. Rosen, and E.S. Lander Reactive oxygen species have a causal role in multiple forms of insulin resistance Nature 440 2006 944 948
12. T. Matsuoka, Y. Kajimoto, H. Watada, H. Kaneto, M. Kishimoto, and Y. Umayahara Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells J Clin Invest 99 1997 144 150
13. B.A. Maddux, W. See, J.C. Lawrence Jr., A.L. Goldfine, I.D. Goldfine, and J.L. Evans Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of alpha-lipoic acid Diabetes 50 2001 404 410
14. K. Nakazono, N. Watanabe, K. Matsuno, J. Sasaki, T. Sato, and M. Inoue Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A 88 1991 10045 10048
15. Y. Ohara, T.E. Peterson, and D.G. Harrison Hypercholesterolemia increases endothelial superoxide anion production J Clin Invest 91 1993 2546 2551
16. M. Brownlee The pathobiology of diabetic complications: a unifying mechanism Diabetes 54 2005 1615 1625
17. T. Inoguchi, P. Li, F. Umeda, H.Y. Yu, M. Kakimoto, and M. Imamura High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells Diabetes 49 2000 1939 1945
18. R. Weindruch, and R.S. Sohal Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging N Engl J Med 337 1997 986 994
19. I. Rebrin, S. Kamzalov, and R.S. Sohal Effects of age and caloric restriction on glutathione redox state in mice Free Radic Biol Med 35 2003 626 635
20. I. Grattagliano, P. Portincasa, T. Cocco, A. Moschetta, M. Di Paola, and V.O. Palmieri Effect of dietary restriction and N-acetylcysteine supplementation on intestinal mucosa and liver mitochondrial redox status and function in aged rats Exp Gerontol 39 2004 1323 1332
21. T. Cocco, P. Sgobbo, M. Clemente, B. Lopriore, I. Grattagliano, and M. Di Paola Tissue-specific changes of mitochondrial functions in aged rats: effect of a long-term dietary treatment with N-acetylcysteine Free Radic Biol Med 38 2005 796 805
22. K.T. Howitz, K.J. Bitterman, H.Y. Cohen, D.W. Lamming, S. Lavu, and J.G. Wood Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 425 2003 191 196
23. J.A. Baur, K.J. Pearson, N.L. Price, H.A. Jamieson, C. Lerin, and A. Kalra Resveratrol improves health and survival of mice on a high-calorie diet Nature 444 2006 337 342
24. J.F. Keaney Jr., M.G. Larson, R.S. Vasan, P.W. Wilson, I. Lipinska, and D. Corey Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study Arterioscler Thromb Vasc Biol 23 2003 434 439
25. Y. Okuno, M. Matsuda, H. Kobayashi, K. Morita, E. Suzuki, and A. Fukuhara Adipose expression of catalase is regulated via a novel remote PPARgamma-responsive region Biochem Biophys Res Commun 366 2008 698 704
26. Y. Okuno, M. Matsuda, Y. Miyata, A. Fukuhara, R. Komuro, and M. Shimabukuro Human catalase gene is regulated by peroxisome proliferator activated receptor-gamma through a response element distinct from that of mouse Endocr J 57 2010 303 309
27. H. Kobayashi, M. Matsuda, A. Fukuhara, R. Komuro, and I. Shimomura Dysregulated glutathione metabolism links to impaired insulin action in adipocytes Am J Physiol Endocrinol Metab 296 2009 E1326 E1334
28. S.K. Fried, D.A. Bunkin, and A.S. Greenberg Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid J Clin Endocrinol Metab 83 1998 847 850
29. P. Sartipy, and D.J. Loskutoff Monocyte chemoattractant protein 1 in obesity and insulin resistance Proc Natl Acad Sci U S A 100 2003 7265 7270
30. J.M. Friedman, and J.L. Halaas Leptin and the regulation of body weight in mammals Nature 395 1998 763 770
31. T. Yamauchi, J. Kamon, H. Waki, Y. Terauchi, N. Kubota, and K. Hara The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nat Med 7 2001 941 946
32. A.H. Berg, T.P. Combs, X. Du, M. Brownlee, and P.E. Scherer The adipocyte-secreted protein Acrp30 enhances hepatic insulin action Nat Med 7 2001 947 953
33. N. Maeda, I. Shimomura, K. Kishida, H. Nishizawa, M. Matsuda, and H. Nagaretani Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 Nat Med 8 2002 731 737
34. Y. Okamoto, S. Kihara, N. Ouchi, M. Nishida, Y. Arita, and M. Kumada Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice Circulation 106 2002 2767 2770
35. M. Matsuda, I. Shimomura, M. Sata, Y. Arita, M. Nishida, and N. Maeda Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis J Biol Chem 277 2002 37487 37491
36. Y. Arita, S. Kihara, N. Ouchi, M. Takahashi, K. Maeda, and J. Miyagawa Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem Biophys Res Commun 257 1999 79 83
37. B.M. Spiegelman, and J.S. Flier Obesity and the regulation of energy balance Cell 104 2001 531 543
38. B.B. Kahn, and J.S. Flier Obesity and insulin resistance J Clin Invest 106 2000 473 481
39. K. Fujita, H. Nishizawa, T. Funahashi, I. Shimomura, and M. Shimabukuro Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome Circ J 70 2006 1437 1442
40. A. Rudich, A. Tirosh, R. Potashnik, R. Hemi, H. Kanety, and N. Bashan Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes Diabetes 47 1998 1562 1569
41. A. Tirosh, R. Potashnik, N. Bashan, and A. Rudich Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation J Biol Chem 274 1999 10595 10602
42. 2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase J Clin Invest 89 1992 1006 1013
43. Y. Matsuzawa, T. Funahashi, and T. Nakamura The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism J Atheroscler Thromb 18 2011 629 639
44. H. Kanda, S. Tateya, Y. Tamori, K. Kotani, K. Hiasa, and R. Kitazawa MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity J Clin Invest 116 2006 1494 1505
45. Y. Tamura, M. Sugimoto, T. Murayama, Y. Ueda, H. Kanamori, and K. Ono Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice Arterioscler Thromb Vasc Biol 28 2008 2195 2201
46. A. Ito, T. Suganami, A. Yamauchi, M. Degawa-Yamauchi, M. Tanaka, and R. Kouyama Role of CC chemokine receptor 2 in bone marrow cells in the recruitment of macrophages into obese adipose tissue J Biol Chem 283 2008 35715 35723
47. T. Suganami, J. Nishida, and Y. Ogawa A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha Arterioscler Thromb Vasc Biol 25 2005 2062 2068
48. T. Suganami, T. Mieda, M. Itoh, Y. Shimoda, Y. Kamei, and Y. Ogawa Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation Biochem Biophys Res Commun 354 2007 45 49
49. H. Shi, M.V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J.S. Flier TLR4 links innate immunity and fatty acid-induced insulin resistance J Clin Invest 116 2006 3015 3025
50. S. Talukdar, Y. Oh da, G. Bandyopadhyay, D. Li, J. Xu, and J. McNelis Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase Nat Med 18 2012 1407 1412
51. L. Lynch, M. Nowak, B. Varghese, J. Clark, A.E. Hogan, and V. Toxavidis Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production Immunity 37 2012 574 587
52. H.S. Schipper, M. Rakhshandehroo, S.F. van de Graaf, K. Venken, A. Koppen, and R. Stienstra Natural killer T cells in adipose tissue prevent insulin resistance J Clin Invest 122 2012 3343 3354
53. M. Curzio, H. Esterbauer, G. Poli, F. Biasi, G. Cecchini, and C. Di Mauro Possible role of aldehydic lipid peroxidation products as chemoattractants Int J Tissue React 9 1987 295 306
54. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
55. D. Jay, H. Hitomi, and K.K. Griendling Oxidative stress and diabetic cardiovascular complications Free Radic Biol Med 40 2006 183 192
56. T. Nishikawa, D. Edelstein, X.L. Du, S. Yamagishi, T. Matsumura, and Y. Kaneda Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Nature 404 2000 787 790
57. S. Sasaki, and T. Inoguchi The role of oxidative stress in the pathogenesis of diabetic vascular complications Diabet Metab J 36 2012 255 261
58. A.Y. Lee, and S.S. Chung Contributions of polyol pathway to oxidative stress in diabetic cataract FASEB J 13 1999 23 30
59. I.G. Obrosova, A.G. Minchenko, R. Vasupuram, L. White, O.I. Abatan, and A.K. Kumagai Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats Diabetes 52 2003 864 871
60. K.V. Ramana, D. Chandra, S. Srivastava, A. Bhatnagar, and S.K. Srivastava Nitric oxide regulates the polyol pathway of glucose metabolism in vascular smooth muscle cells FASEB J 17 2003 417 425
61. C. Yabe-Nishimura Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications Pharmacol Rev 50 1998 21 33
62. D.M. Morre, G. Lenaz, and D.J. Morre Surface oxidase and oxidative stress propagation in aging J Exp Biol 203 2000 1513 1521
63. G. Basta, A.M. Schmidt, and R. De Caterina Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes Cardiovasc Res 63 2004 582 592
64. H. Kaneto, Y. Kajimoto, J. Miyagawa, T. Matsuoka, Y. Fujitani, and Y. Umayahara Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity Diabetes 48 1999 2398 2406
65. T.A. Matsuoka, L. Zhao, I. Artner, H.W. Jarrett, D. Friedman, and A. Means Members of the large Maf transcription family regulate insulin gene transcription in islet beta cells Mol Cell Biol 23 2003 6049 6062
66. D. Kawamori, Y. Kajimoto, H. Kaneto, Y. Umayahara, Y. Fujitani, and T. Miyatsuka Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH(2)-terminal kinase Diabetes 52 2003 2896 2904
67. X. Zhang, F. Dong, J. Ren, M.J. Driscoll, and B. Culver High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex Exp Neurol 191 2005 318 325
68. A. Nagae, M. Fujita, H. Kawarazaki, H. Matsui, K. Ando, and T. Fujita Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension Circulation 119 2009 978 986
69. S. Rajagopalan, S. Kurz, T. Munzel, M. Tarpey, B.A. Freeman, and K.K. Griendling Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone J Clin Invest 97 1996 1916 1923
70. K.K. Griendling, D. Sorescu, and M. Ushio-Fukai NAD(P)H oxidase: role in cardiovascular biology and disease Circ Res 86 2000 494 501
71. R.C. Frederich Jr., B.B. Kahn, M.J. Peach, and J.S. Flier Tissue-specific nutritional regulation of angiotensinogen in adipose tissue Hypertension 19 1992 339 344
72. A. Prasad, and A.A. Quyyumi Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome Circulation 110 2004 1507 1512
73. G.H. Goossens, E.E. Blaak, and M.A. van Baak Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders Obes Rev 4 2003 43 55
74. A. Kurata, H. Nishizawa, S. Kihara, N. Maeda, M. Sonoda, and T. Okada Blockade of angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation Kidney Int 70 2006 1717 1724
75. R. Stocker, and J.F. Keaney Jr. Role of oxidative modifications in atherosclerosis Physiol Rev 84 2004 1381 1478
76. T.J. Guzik, J. Sadowski, B. Kapelak, A. Jopek, P. Rudzinski, and R. Pillai Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins Arterioscler Thromb Vasc Biol 24 2004 1614 1620
77. S. Spiekermann, U. Landmesser, S. Dikalov, M. Bredt, G. Gamez, and H. Tatge Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation Circulation 107 2003 1383 1389
78. T. Heitzer, T. Schlinzig, K. Krohn, T. Meinertz, and T. Munzel Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease Circulation 104 2001 2673 2678
79. H. Azumi, N. Inoue, Y. Ohashi, M. Terashima, T. Mori, and H. Fujita Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase Arterioscler Thromb Vasc Biol 22 2002 1838 1844
80. H.N. Ginsberg Insulin resistance and cardiovascular disease J Clin Invest 106 2000 453 458
81. K.K. Berneis, and R.M. Krauss Metabolic origins and clinical significance of LDL heterogeneity J Lipid Res 43 2002 1363 1379
82. F. Nappo, K. Esposito, M. Cioffi, G. Giugliano, A.M. Molinari, and G. Paolisso Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals J Am Coll Cardiol 39 2002 1145 1150
83. A. Ceriello, C. Taboga, L. Tonutti, L. Quagliaro, L. Piconi, and B. Bais Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment Circulation 106 2002 1211 1218
84. R.A. Anderson, M.L. Evans, G.R. Ellis, J. Graham, K. Morris, and S.K. Jackson The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes Atherosclerosis 154 2001 475 483
85. G.D. Plotnick, M.C. Corretti, and R.A. Vogel Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal JAMA 278 1997 1682 1686
86. C.F. Semenkovich Insulin resistance and atherosclerosis J Clin Invest 116 2006 1813 1822
87. M.R. Taskinen Diabetic dyslipidaemia: from basic research to clinical practice Diabetologia 46 2003 733 749
88. T. Gordon, W.P. Castelli, M.C. Hjortland, W.B. Kannel, and T.R. Dawber High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study Am J Med 62 1977 707 714
89. A.R. Tall An overview of reverse cholesterol transport Eur Heart J 19 Suppl. A 1998 A31 A35
90. M. Navab, S.S. Imes, S.Y. Hama, G.P. Hough, L.A. Ross, and R.W. Bork Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein J Clin Invest 88 1991 2039 2046
91. B.J. Van Lenten, S.Y. Hama, F.C. de Beer, D.M. Stafforini, T.M. McIntyre, and S.M. Prescott Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures J Clin Invest 96 1995 2758 2767
92. A.D. Watson, J.A. Berliner, S.Y. Hama, B.N. La Du, K.F. Faull, and A.M. Fogelman Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein J Clin Invest 96 1995 2882 2891
93. M. Briel, I. Ferreira-Gonzalez, J.J. You, P.J. Karanicolas, E.A. Akl, and P. Wu Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis BMJ 338 2009 b92
94. L. Persegol, B. Verges, P. Gambert, and L. Duvillard Inability of HDL from abdominally obese subjects to counteract the inhibitory effect of oxidized LDL on vasorelaxation J Lipid Res 48 2007 1396 1401
95. S.J. Nicholls, L. Zheng, and S.L. Hazen Formation of dysfunctional high-density lipoprotein by myeloperoxidase Trends Cardiovasc Med 15 2005 212 219
96. S. Cowey, and R.W. Hardy The metabolic syndrome: a high-risk state for cancer? Am J Pathol 169 2006 1505 1522
97. E.J. Gallagher, and D. LeRoith Minireview: IGF, insulin, and cancer Endocrinology 152 2011 2546 2551
98. I. Vucenik, and J.P. Stains Obesity and cancer risk: evidence, mechanisms, and recommendations Ann N Y Acad Sci 1271 2012 37 43
99. J. Gao, J. Tian, Y. Lv, F. Shi, F. Kong, and H. Shi Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells Cancer Sci 100 2009 389 395
100. T. Jaffe, and B. Schwartz Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways Int J Cancer 123 2008 2543 2556
101. T. Nishihara, M. Baba, M. Matsuda, M. Inoue, Y. Nishizawa, and A. Fukuhara Adiponectin deficiency enhances colorectal carcinogenesis and liver tumor formation induced by azoxymethane in mice World J Gastroenterol 14 2008 6473 6480
102. Y. Kamada, H. Matsumoto, S. Tamura, J. Fukushima, S. Kiso, and K. Fukui Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model J Hepatol 47 2007 556 564
103. A.E. Harvey, L.M. Lashinger, and S.D. Hursting The growing challenge of obesity and cancer: an inflammatory issue Ann N Y Acad Sci 1229 2011 45 52
104. S.D. Hursting, and N.A. Berger Energy balance, host-related factors, and cancer progression J Clin Oncol 28 2010 4058 4065
105. T. Fiaschi, and P. Chiarugi Oxidative stress, tumor microenvironment, and metabolic reprogramming: a diabolic liaison Int J Cell Biol 2012 2012 762825
106. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
107. L.J. Marnett Oxyradicals and DNA damage Carcinogenesis 21 2000 361 370
108. P. Storz Reactive oxygen species in tumor progression Front Biosci 10 2005 1881 1896
109. D. Ferraro, S. Corso, E. Fasano, E. Panieri, R. Santangelo, and S. Borrello Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS) Oncogene 25 2006 3689 3698
110. M. Shinohara, W.H. Shang, M. Kubodera, S. Harada, J. Mitsushita, and M. Kato Nox1 redox signaling mediates oncogenic Ras-induced disruption of stress fibers and focal adhesions by down-regulating Rho J Biol Chem 282 2007 17640 17648
111. G. Svineng, C. Ravuri, O. Rikardsen, N.E. Huseby, and J.O. Winberg The role of reactive oxygen species in integrin and matrix metalloproteinase expression and function Connect Tissue Res 49 2008 197 202
112. N. Maulik Redox signaling of angiogenesis Antioxid Redox signal 4 2002 805 815
113. G.L. Semenza Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics Oncogene 29 2010 625 634
114. R.S. Rosenson, C.C. Tangney, and L.C. Casey Inhibition of proinflammatory cytokine production by pravastatin Lancet 353 1999 983 984
115. J.L. Martin-Ventura, L.M. Blanco-Colio, A. Gomez-Hernandez, B. Munoz-Garcia, M. Vega, and J. Serrano Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month Stroke 36 2005 1796 1800
116. M. Abe, M. Matsuda, H. Kobayashi, Y. Miyata, Y. Nakayama, and R. Komuro Effects of statins on adipose tissue inflammation: their inhibitory effect on MyD88-independent IRF3/IFN-beta pathway in macrophages Arterioscler Thromb Vasc Biol 28 2008 871 877
117. H. Tsubouchi, T. Inoguchi, T. Sonta, N. Sato, N. Sekiguchi, and K. Kobayashi Statin attenuates high glucose-induced and diabetes-induced oxidative stress in vitro and in vivo evaluated by electron spin resonance measurement Free Radic Biol Med 39 2005 444 452